BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 30422241)

  • 1. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
    Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
    JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
    Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
    Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
    Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
    BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
    Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
    Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection.
    Li SH; Guo ZX; Xiao CZ; Wei W; Shi M; Chen ZY; Cai MY; Zheng L; Guo RP
    Asian Pac J Cancer Prev; 2013; 14(8):4759-63. PubMed ID: 24083739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.
    Marasco G; Colecchia A; Colli A; Ravaioli F; Casazza G; Bacchi Reggiani ML; Cucchetti A; Cescon M; Festi D
    J Hepatol; 2019 Mar; 70(3):440-448. PubMed ID: 30389551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.
    Shah SA; Wei AC; Cleary SP; Yang I; McGilvray ID; Gallinger S; Grant DR; Greig PD
    J Gastrointest Surg; 2007 May; 11(5):589-95. PubMed ID: 17393258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
    Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
    J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
    Sasaki K; Shindoh J; Margonis GA; Nishioka Y; Andreatos N; Sekine A; Hashimoto M; Pawlik TM
    JAMA Surg; 2017 Mar; 152(3):e165059. PubMed ID: 28052155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.
    Kim PT; Jang JH; Atenafu EG; Fischer S; Greig PD; McGilvray ID; Wei AC; Gallinger S; Cleary SP
    Br J Surg; 2013 Oct; 100(11):1516-22. PubMed ID: 24037575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
    Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
    Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
    Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
    Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma.
    Kim SU; Jung KS; Lee S; Park JY; Kim DY; Ahn SH; Choi GH; Kim KS; Choi JS; Han KH; Park YN
    Liver Int; 2014 Aug; 34(7):1008-17. PubMed ID: 24483989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
    JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.